Pre-Clinical Studies of Allogeneic Anti-CD123 CAR T-Cells for the Therapy of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

被引:0
|
作者
Cai, Tianyu
Galetto, Roman
Gouble, Agnes
Smith, Julianne
Cavazos, Antonio
Han, Lina
Zhang, Qi
Kuruvilla, Vinitha Mary
Konoplev, Sergej Naumovich
Neelapu, Sattva S.
Lane, Andrew A.
Guzman, Monica L.
Kantarjian, Hagop M.
Pemmaraju, Naveen
Konopleva, Marina
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2625
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Pre-Clinical Studies of Anti-CD123 CAR-T Cells for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Cai, Tianyu
    Galetto, Roman
    Gouble, Agnes
    Smith, Julianne
    Cavazos, Antonio
    Konoplev, Sergej
    Lane, Andrew A.
    Guzman, Monica L.
    Kantarjian, Hagop M.
    Pemmaraju, Naveen
    Konopleva, Marina
    BLOOD, 2016, 128 (22)
  • [2] Preclinical efficacy of allogeneic anti-CD123 CAR T-cells for the therapy of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
    Cai, Tianyu
    Black, Kathryn L.
    Naqvi, Ammar
    Galetto, Roman
    Gouble, Agnes
    Smith, Julianne
    Cavazos, Antonio
    Han, Lina
    Zhang, Qi
    Kuruvilla, Vinitha
    Konoplev, Sergej Naumovich Sergej
    Neelapu, Sattva S.
    Lane, Andrew A.
    Guzman, Monica L.
    Kantarjian, Hagop
    Thomas-Tikhonenko, Andrei
    Pemmaraju, Naveen
    Konopleva, Marina
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
    Tianyu Cai
    Agnès Gouble
    Kathryn L. Black
    Anna Skwarska
    Ammar S. Naqvi
    Deanne Taylor
    Ming Zhao
    Qi Yuan
    Mayumi Sugita
    Qi Zhang
    Roman Galetto
    Stéphanie Filipe
    Antonio Cavazos
    Lina Han
    Vinitha Kuruvilla
    Helen Ma
    Connie Weng
    Chang-Gong Liu
    Xiuping Liu
    Sergej Konoplev
    Jun Gu
    Guilin Tang
    Xiaoping Su
    Gheath Al-Atrash
    Stefan Ciurea
    Sattva S. Neelapu
    Andrew A. Lane
    Hagop Kantarjian
    Monica L. Guzman
    Naveen Pemmaraju
    Julianne Smith
    Andrei Thomas-Tikhonenko
    Marina Konopleva
    Nature Communications, 13
  • [4] Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
    Cai, Tianyu
    Gouble, Agnes
    Black, Kathryn L.
    Skwarska, Anna
    Naqvi, Ammar S.
    Taylor, Deanne
    Zhao, Ming
    Yuan, Qi
    Sugita, Mayumi
    Zhang, Qi
    Galetto, Roman
    Filipe, Stephanie
    Cavazos, Antonio
    Han, Lina
    Kuruvilla, Vinitha
    Ma, Helen
    Weng, Connie
    Liu, Chang-Gong
    Liu, Xiuping
    Konoplev, Sergej
    Gu, Jun
    Tang, Guilin
    Su, Xiaoping
    Al-Atrash, Gheath
    Ciurea, Stefan
    Neelapu, Sattva S.
    Lane, Andrew A.
    Kantarjian, Hagop
    Guzman, Monica L.
    Pemmaraju, Naveen
    Smith, Julianne
    Thomas-Tikhonenko, Andrei
    Konopleva, Marina
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [5] Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hope
    Cangini, Delia
    Silimbani, Paolo
    Cafaro, Alessandro
    Giannini, Maria B.
    Masini, Carla
    Di Rora, Andrea Ghelli Luserna
    Simonetti, Giorgia
    Martinelli, Giovanni
    Cerchione, Claudio
    MINERVA MEDICA, 2020, 111 (05) : 467 - 477
  • [6] Optimization of the CD123 CAR T-cell scFv for the treatment of patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Fredon, M.
    Poussard, M.
    Biichle, S.
    Anna, F.
    Bonnefoy, F.
    Bole-Richard, E.
    Renosi, F.
    Caumartin, J.
    Loustau, M.
    Adotevi, O.
    Saas, P.
    Angelot-Delettre, F.
    Galaine, J.
    Garnache-Ottou, F.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A37 - A37
  • [7] CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights
    Pemmaraju, Naveen
    Wilson, Nathaniel R.
    Senapati, Jayastu
    Economides, Minas P.
    Guzman, Monica L.
    Neelapu, Sattva S.
    Kazemimood, Rossana
    Davis, Richard Eric
    Jain, Nitin
    Khoury, Joseph D.
    Sugita, Mayumi
    Cai, Tianyu
    Smith, Julianne
    Frattini, Mark G.
    Garton, Andrew
    Roboz, Gail
    Konopleva, Marina
    LEUKEMIA RESEARCH, 2022, 121
  • [8] Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in Pediatric Patients with Tagraxofusp, a CD123-Targeted Therapy
    Pemmaraju, Naveen
    Cuglievan, Branko
    Lasky, Joseph L., III
    Kheradpour, Albert
    Hijiya, Nobuko
    Stein, Anthony S.
    Pawlowska, Anna B.
    BLOOD, 2021, 138
  • [9] Tagraxofusp, a CD123-Targeted Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Landmark Clinical Trial
    Pemmaraju, Naveen
    Lane, Andrew
    Sweet, Kendra
    Stein, Anthony
    Vasu, Sumithira
    Blum, William
    Rizzieri, David
    Wang, Eunice
    Duvic, Madeleine
    Brooks, Christopher
    Sloan, J. Mark
    Rosenblat, Todd
    Akilov, Oleg
    Mughal, Tariq
    Lancet, Jeffrey
    Kantarjian, Hagop
    Konopleva, Marina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S209 - S210
  • [10] Tagraxofusp, an Anti-CD123 Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: Subanalyses of a Pivotal Trial By Age and Baseline Disease Involvement
    Pemmaraju, Naveen
    Konopleva, Marina
    Sweet, Kendra
    Stein, Anthony S.
    Vasu, Sumithira
    Rizzieri, David A.
    Wang, Eunice S.
    Kantarjian, Hagop
    Brooks, Christopher L.
    Mughal, Tariq I.
    Lane, Andrew A.
    BLOOD, 2021, 138